We are delighted to share that BERKEN IP has once again ranked in the “IAM Patent 1000: The World’s Leading Patent Professionals” guide. Three of our Partners have been recognized as top patent professionals in 2021: Pedro Berkenwald, Alicia Alvarez Berkenwald and Federico Ulled. Emilio Berkenwald deserves a special mention for making his debut this year! IAM has described him as “a future leader of the patent practice”.
Our Managing Partner Alicia Alvarez Berkenwald has been recognized by IAM as a Global Leader in Patents in the just released 2021 IAM Global Leaders Guide. Congratulations Alicia! #IAM #Patents #IAMGlobalLeaders
Don´t miss out on INTAconnect: the virtual networking platform for #INTA2020! Please feel free to request a meeting with Lucía Scarpati and Bárbara Porcario through INTAconnect #INTA #trademarks #INTAconnect
Join our speakers Emilio Berkenwald and Lucía Scarpati on a webinar about Argentine IP Law during the Centre d’Etudes Internationales de la Propriété Intellectuelle – CEIPI Comparative Law Seminar!
The event is free and will be broadcasted in French.
Please click here to register.
It was a great pleasure hosting the 2020 American Intellectual Property Law Association (AIPLA) Women in IP Virtual Global Networking Event in Buenos Aires! A very inspiring session on leadership, gender and diversity. A great thank you to all the attendees for joining us online this year #WIPNE #AIPLA #WomeninIP
USPTO Pilot Program enables deferred-fee payment related to filing of provisional patent applications that combat COVID-19
The United States Patent and Trademark Office (USPTO) launched a pilot program that allows deferring the payment of filing official fees for provisional patent applications that combat COVID-19, until the filing of a corresponding non-provisional application.
The applicants must agree that the technical subject matter disclosed in their provisional applications will be available to the public on USPTO’s website.
In this way, two objectives are achieved: by disseminating the technology, applicants contribute to the fight against COVID-19 while at the same time protecting their patent rights.
To qualify for the program, the subject matter disclosed in the provisional must concern a product or process related to COVID-19, and such product or process requires Food and Drug Administration (FDA) approval for COVID-19 use.
The program accepts applications as from September 17, 2020, for a duration of 12 months.
For more information, please click here.
Very proud to be ranked in @Leaders League 2020 in #iplitigation, #patent prosecution and #trademark prosecution in Argentina. Congratulations to Pedro Berkenwald, Alicia Alvarez Berkenwald, Ernesto Machicote, Federico Ulled and Barbara Porcario! #leadersleague
Procedure for expanding production categories
Procedure for carrying out the initial authorization of a company
Procedure for expanding production through authorized third parties
Regulatory Affairs & Compliance